AI assistant
CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2021
Dec 6, 2021
31542_dirs_2021-12-06_911c1829-0314-4164-847b-0c5ece5c32a0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2021-12-03
Reporting Person: Elsbernd Brian (Chief Compliance/Legal Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-12-03 | Common Stock, par value $0.001 per share | M | 14667 | — | Acquired | 29333 | Direct |
| 2021-12-03 | Common Stock, par value $0.001 per share | F | 3571 | — | Disposed | 25762 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-12-03 | Restricted Stock Units | $ | M | 14667 | Disposed | Common Stock (14667) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
F2: Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted stock units.
F3: Derivative securities vest in equal tranches, 1/3rd on December 2, 2020, 1/3rd on December 2, 2021 and 1/3rd on December 2, 2022.
F4: Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The second tranche of shares was delivered on December 3, 2021.